70 related articles for article (PubMed ID: 23559539)
1. AMPK synergizes with the combined treatment of 1'-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities.
Yaku K; Matsui-Yuasa I; Konishi Y; Kojima-Yuasa A
Mol Nutr Food Res; 2013 Jul; 57(7):1198-208. PubMed ID: 23559539
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effect of 1'-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells.
Kato R; Matsui-Yuasa I; Azuma H; Kojima-Yuasa A
Chem Biol Interact; 2014 Apr; 212():1-10. PubMed ID: 24480522
[TBL] [Abstract][Full Text] [Related]
3. 1'-Acetoxychavicol acetate enhances the phase II enzyme activities via the increase in intranuclear Nrf2 level and cytosolic p21 level.
Yaku K; Matsui-Yuasa I; Azuma H; Kojima-Yuasa A
Am J Chin Med; 2011; 39(4):789-802. PubMed ID: 21721157
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53.
Yaku K; Enami Y; Kurajyo C; Matsui-Yuasa I; Konishi Y; Kojima-Yuasa A
Mol Cell Biochem; 2012 Nov; 370(1-2):7-14. PubMed ID: 22806321
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Street CR; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):733-40. PubMed ID: 22209714
[TBL] [Abstract][Full Text] [Related]
6. Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats.
Wiegand H; Boesch-Saadatmandi C; Regos I; Treutter D; Wolffram S; Rimbach G
Nutr Cancer; 2009; 61(5):717-22. PubMed ID: 19838946
[TBL] [Abstract][Full Text] [Related]
7. [Regulation mechanism of triterpenoid components from Prunella asiatica on phase II detoxifying enzymes in vitro and in vivo].
Jin P; Tan XB; Liu WB; Jia XB
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3637-40. PubMed ID: 23477155
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
9. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
10. Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells.
Zhu L; Liu Z; Feng Z; Hao J; Shen W; Li X; Sun L; Sharman E; Wang Y; Wertz K; Weber P; Shi X; Liu J
J Nutr Biochem; 2010 Nov; 21(11):1089-98. PubMed ID: 20149621
[TBL] [Abstract][Full Text] [Related]
11. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
[TBL] [Abstract][Full Text] [Related]
12. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary genistein on Phase II and antioxidant enzymes in rat liver.
Wiegand H; Wagner AE; Boesch-Saadatmandi C; Kruse HP; Kulling S; Rimbach G
Cancer Genomics Proteomics; 2009; 6(2):85-92. PubMed ID: 19451092
[TBL] [Abstract][Full Text] [Related]
14. Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants.
Yoshinari K; Okino N; Sato T; Sugatani J; Miwa M
Drug Metab Dispos; 2006 Jul; 34(7):1081-9. PubMed ID: 16581946
[TBL] [Abstract][Full Text] [Related]
15. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium.
Seo JY; Lim SS; Kim JR; Lim JS; Ha YR; Lee IA; Kim EJ; Park JH; Kim JS
Phytother Res; 2008 Nov; 22(11):1500-5. PubMed ID: 18702092
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
17. Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines.
Krajka-Kuźniak V; Paluszczak J; Szaefer H; Baer-Dubowska W
Br J Nutr; 2013 Dec; 110(12):2138-49. PubMed ID: 23769299
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.
Arshad NM; In LL; Soh TL; Azmi MN; Ibrahim H; Awang K; Dudich E; Tatulov E; Nagoor NH
Oncotarget; 2015 Jun; 6(18):16151-67. PubMed ID: 26158863
[TBL] [Abstract][Full Text] [Related]
19. Butyrate alleviates oxidative stress by regulating NRF2 nuclear accumulation and H3K9/14 acetylation via GPR109A in bovine mammary epithelial cells and mammary glands.
Guo W; Liu J; Sun J; Gong Q; Ma H; Kan X; Cao Y; Wang J; Fu S
Free Radic Biol Med; 2020 May; 152():728-742. PubMed ID: 31972340
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells.
Kang SJ; You A; Kwak MK
Arch Pharm Res; 2011 May; 34(5):829-36. PubMed ID: 21656369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
